Yoko Hasumi

715 total citations
29 papers, 521 citations indexed

About

Yoko Hasumi is a scholar working on Obstetrics and Gynecology, Surgery and Molecular Biology. According to data from OpenAlex, Yoko Hasumi has authored 29 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Yoko Hasumi's work include Endometrial and Cervical Cancer Treatments (9 papers), Virus-based gene therapy research (4 papers) and Endometriosis Research and Treatment (4 papers). Yoko Hasumi is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Virus-based gene therapy research (4 papers) and Endometriosis Research and Treatment (4 papers). Yoko Hasumi collaborates with scholars based in Japan, Sweden and Pakistan. Yoko Hasumi's co-authors include Carina Hellberg, Akihiro Kume, Keiya Ozawa, Masashi Urabe, KAZUO SHIZUME, Hiroyuki Yoshikawa, Kazue Takano, Masao Furuhashi, Carl‐Henrik Heldin and Arne Östman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Yoko Hasumi

28 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Hasumi Japan 14 242 133 116 97 90 29 521
John D. Nash United States 12 177 0.7× 162 1.2× 74 0.6× 254 2.6× 78 0.9× 20 595
H. Caffier Germany 15 332 1.4× 216 1.6× 90 0.8× 137 1.4× 187 2.1× 42 679
Marzenna Orlowska‐Volk Germany 15 307 1.3× 258 1.9× 68 0.6× 179 1.8× 88 1.0× 27 810
Rudi Henriksen Sweden 9 276 1.1× 223 1.7× 68 0.6× 247 2.5× 46 0.5× 15 643
Shay Hantisteanu Israel 14 217 0.9× 93 0.7× 54 0.5× 85 0.9× 29 0.3× 30 559
David L. Tait United States 16 239 1.0× 158 1.2× 115 1.0× 154 1.6× 162 1.8× 40 531
Phillip Koeffler United States 11 277 1.1× 95 0.7× 40 0.3× 27 0.3× 79 0.9× 22 599
Bong Ryoul Oh United States 13 463 1.9× 92 0.7× 63 0.5× 50 0.5× 181 2.0× 23 798
Amiram Fishman Israel 13 120 0.5× 119 0.9× 115 1.0× 273 2.8× 229 2.5× 17 622
Maxine L. Crook Australia 17 211 0.9× 136 1.0× 211 1.8× 199 2.1× 29 0.3× 35 613

Countries citing papers authored by Yoko Hasumi

Since Specialization
Citations

This map shows the geographic impact of Yoko Hasumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Hasumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Hasumi more than expected).

Fields of papers citing papers by Yoko Hasumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Hasumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Hasumi. The network helps show where Yoko Hasumi may publish in the future.

Co-authorship network of co-authors of Yoko Hasumi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Hasumi. A scholar is included among the top collaborators of Yoko Hasumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Hasumi. Yoko Hasumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Onda, Takashi, Yumiko Tanaka, Mitsuya Ishikawa, et al.. (2020). Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602. Japanese Journal of Clinical Oncology. 51(2). 205–212. 8 indexed citations
3.
4.
Okamoto, Hiroyuki, Naoya Murakami, Fumiaki Isohashi, et al.. (2019). Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Radiation Oncology. 14(1). 133–133. 7 indexed citations
5.
Isohashi, Fumiaki, Tadao Takano, Mamiko Onuki, et al.. (2018). A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors. International Journal of Clinical Oncology. 24(5). 575–582. 11 indexed citations
6.
Sato, Masakazu, et al.. (2018). Gynecologists May Underestimate the Amount of Blood Loss during Total Laparoscopic Hysterectomy. Obstetrics and Gynecology International. 2018. 1–5. 4 indexed citations
7.
Ishikawa, Mitsuya, Takahiro Kasamatsu, Hitoshi Tsuda, et al.. (2017). Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study. Gynecologic Oncology. 148(1). 139–146. 47 indexed citations
8.
Takano, Masashi, Hiroyuki Ochi, Yuji Takei, et al.. (2013). Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?. British Journal of Cancer. 109(7). 1760–1765. 32 indexed citations
9.
Matsuzaki, Masayo, et al.. (2010). Ubiquinol-10 and ubiquinone-10 levels in umbilical cord blood of healthy foetuses and the venous blood of their mothers. Free Radical Research. 44(11). 1338–1344. 5 indexed citations
10.
Hasumi, Yoko, et al.. (2010). Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor. Melanoma Research. 21(1). 57–65. 9 indexed citations
11.
Hasumi, Yoko, Mikhail Burmakin, Aive Åhgren, et al.. (2009). Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma. PLoS ONE. 4(12). e8149–e8149. 40 indexed citations
12.
Hasumi, Yoko, et al.. (2007). Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. International Journal of Cancer. 121(12). 2606–2614. 55 indexed citations
13.
Takei, Yuji, Hiroaki Mizukami, Yasushi Saga, et al.. (2006). Suppression of ovarian cancer by muscle‐mediated expression of soluble VEGFR‐1/Flt‐1 using adeno‐associated virus serotype 1‐derived vector. International Journal of Cancer. 120(2). 278–284. 27 indexed citations
14.
Matsumoto, Koji, Hiroyuki Yoshikawa, Toshiharu Yasugi, et al.. (2002). Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Letters. 180(1). 83–89. 37 indexed citations
15.
Matsuda, Kant, Seiji Madoiwa, Yoko Hasumi, et al.. (2000). A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer. Cancer Gene Therapy. 7(4). 589–596. 21 indexed citations
16.
Urabe, Masashi, Yoko Hasumi, Yoji Ogasawara, et al.. (1997). A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome. Gene. 200(1-2). 157–162. 32 indexed citations
17.
Takano, Kazue, et al.. (1981). Effect of food and GH on the binding of 125I-somatomedin a to the membranes of rat lung and kidney.. Endocrinologia Japonica. 28(5). 669–675. 1 indexed citations
18.
Takano, Kazue, Naomi Hizuka, KAZUO SHIZUME, Yoko Hasumi, & Toshio Tsushima. (1980). Effect of nutrition on growth and somatomedin A levels in the rat. European Journal of Endocrinology. 94(3). 321–326. 16 indexed citations
19.
Hasumi, Yoko, et al.. (1980). Effect of thyroid hormone on the serum level of somatomedin A.. Endocrinologia Japonica. 27(5). 643–652. 4 indexed citations
20.
Takano, Kazue, Naomi Hizuka, KAZUO SHIZUME, & Yoko Hasumi. (1979). SERUM LEVELS OF SOMATOMEDIN A AND GROWTH DURING LONG-TERM TREATMENT OF PATIENTS WITH PITUITARY DWARFISM WITH HUMAN GROWTH HORMONE. European Journal of Endocrinology. 92(3). 385–397. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John D. Nash Breakdown of academic impact, for papers by H. Caffier Breakdown of academic impact, for papers by Marzenna Orlowska‐Volk Breakdown of academic impact, for papers by Rudi Henriksen Breakdown of academic impact, for papers by Shay Hantisteanu Breakdown of academic impact, for papers by David L. Tait Breakdown of academic impact, for papers by Phillip Koeffler Breakdown of academic impact, for papers by Bong Ryoul Oh Breakdown of academic impact, for papers by Amiram Fishman Breakdown of academic impact, for papers by Maxine L. Crook
Rankless by CCL
2026